MX2013002007A - Dispositivos y métodos para administración intravaginal de fármacos y otras sustancias. - Google Patents

Dispositivos y métodos para administración intravaginal de fármacos y otras sustancias.

Info

Publication number
MX2013002007A
MX2013002007A MX2013002007A MX2013002007A MX2013002007A MX 2013002007 A MX2013002007 A MX 2013002007A MX 2013002007 A MX2013002007 A MX 2013002007A MX 2013002007 A MX2013002007 A MX 2013002007A MX 2013002007 A MX2013002007 A MX 2013002007A
Authority
MX
Mexico
Prior art keywords
devices
methods
drugs
substances
intravaginal delivery
Prior art date
Application number
MX2013002007A
Other languages
English (en)
Inventor
Patrick F Kiser
Vlad G O Mel
Leland J Prather
Festo Damian
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Publication of MX2013002007A publication Critical patent/MX2013002007A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente tecnología proporciona dispositivos intravaginales diseñados para liberar dentro de la vagina moléculas y macromoléculas solubles en agua de difícil formulación durante un período de tiempo sostenido. Los dispositivos incluyen una cámara que tiene al menos un orificio y que contiene una formulación de liberación sostenida. Tales formulaciones incluyen un polímero hinchable en agua y una sustancia administrable por vía intravaginal. También se proporcionan métodos para crear y utilizar los dispositivos.
MX2013002007A 2010-08-20 2011-08-19 Dispositivos y métodos para administración intravaginal de fármacos y otras sustancias. MX2013002007A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37567110P 2010-08-20 2010-08-20
PCT/US2011/048453 WO2012024605A2 (en) 2010-08-20 2011-08-19 Devices and methods for intravaginal delivery of drugs and other substances

Publications (1)

Publication Number Publication Date
MX2013002007A true MX2013002007A (es) 2013-05-17

Family

ID=45605694

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002007A MX2013002007A (es) 2010-08-20 2011-08-19 Dispositivos y métodos para administración intravaginal de fármacos y otras sustancias.

Country Status (9)

Country Link
US (1) US20130220337A1 (es)
EP (1) EP2605779A4 (es)
KR (1) KR20130091760A (es)
CN (1) CN103327985A (es)
BR (1) BR112013003936A2 (es)
CA (1) CA2844292A1 (es)
MX (1) MX2013002007A (es)
RU (1) RU2013111303A (es)
WO (1) WO2012024605A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014123880A1 (en) 2013-02-05 2014-08-14 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
US20180015270A1 (en) * 2015-01-30 2018-01-18 Ligalli B.V. Vaginal Drug Delivery Device
CN106821585A (zh) * 2017-01-26 2017-06-13 健务（上海）生物科技有限公司 新型避孕药具
CN106581843A (zh) * 2017-01-26 2017-04-26 优仕康生（天津）科技发展有限公司 具有高锁持性及高通透性的阴道、肛肠给药载体
JP2023503642A (ja) * 2019-11-27 2023-01-31 オーク クレスト インスティテュート オブ サイエンス 徐放性薬物送達デバイス
WO2023204734A1 (ru) * 2022-04-21 2023-10-26 Общество С Ограниченной Ответственностью "Кинетик-Фарм" Средство для интравагинальной доставки активного компонента, способ получения и применения средства

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
EP1646363B1 (en) * 2003-07-10 2013-10-16 Warner Chilcott (Ireland) Limited Intravaginal drug delivery devices
US20050239742A1 (en) * 2004-04-08 2005-10-27 Vivus, Inc. Carrageenan-based formulations and associated methods of use
US20080268022A1 (en) * 2007-02-23 2008-10-30 Mccabe R Tyler Mehtods for treating and preventing ailments caused by human papillomavirus
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
WO2009094573A2 (en) * 2008-01-25 2009-07-30 The University Of Utah Research Foundation Linear order release polymer

Also Published As

Publication number Publication date
EP2605779A4 (en) 2015-06-24
EP2605779A2 (en) 2013-06-26
RU2013111303A (ru) 2014-09-27
CN103327985A (zh) 2013-09-25
WO2012024605A3 (en) 2012-04-26
WO2012024605A2 (en) 2012-02-23
KR20130091760A (ko) 2013-08-19
US20130220337A1 (en) 2013-08-29
BR112013003936A2 (pt) 2017-11-14
CA2844292A1 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
MX2013002007A (es) Dispositivos y métodos para administración intravaginal de fármacos y otras sustancias.
CA2895175C (en) Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
GB2545368A (en) Diversion-resistant opioid formulations
IL202614A0 (en) Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs
NZ727975A (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
UA115131C2 (uk) Сполуки боронатного ефіру і його фармацевтичні рецептури
WO2007092620A3 (en) Stable formulations, and methods of their preparation and use
SG162798A1 (en) Liquid pharmaceutical formulations of docetaxel
MX355833B (es) Metodo y formulacion para inhalacion.
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
IN2012DN01216A (es)
WO2010121177A3 (en) Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
MX2014008284A (es) Formulacion de liberacion retardada para reducir la frecuencia de orinar y metodos de uso de esta.
NZ602442A (en) A fast dissolving pharmaceutical composition
MX2015008286A (es) Composiciones multipolimericas para liberación transdermica de farmaco.
MX2014008283A (es) Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
BR112016006171A2 (pt) formulações de espuma e dispositivo para sua entrega
CL2011002807A1 (es) Mezcla farmaceutica comprimible que comprende cristales de un farmaco con tamaño de particulas inferior a 40 um y un adyuvante de la disolucion; procedimiento para preparar un vehiculo de administracion para un farmaco que incluye moler una premezcla de cristales de farmaco y un adyuvante de la disolucion.
NZ718163A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
PH12015502556A1 (en) Modified release formulation
MX2013012206A (es) Metodo para producir substancias con gas sobresaturado,dispositivo de suministro transdermico de las mismas, y usos de las mismas.
MX2013013691A (es) Composicion de liberacion sostenida que contiene peptidos como ingredientes activos.
EA201390911A1 (ru) Фармацевтическая композиция, содержащая растительное действующее вещество
MX2013012204A (es) Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.
MX336462B (es) Polimero no digerible: recubrimientos de pelicula basados en acetato de almidon dirigidos al colon.